Seeking Alpha

Pfizer (PFE) announces a deal worth up to $725M to develop and commercialize Medivation's (MDVN)...

Pfizer (PFE) announces a deal worth up to $725M to develop and commercialize Medivation's (MDVN) Alzheimer's drug. Pfizer is trying to expand its product pipeline before blockbuster Lipitor loses its patent protection. Pre-market: MDVN +28%.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs